US Stock MarketDetailed Quotes

EYPT EyePoint Pharmaceuticals

Watchlist
  • 18.550
  • +0.950+5.40%
Trading May 1 15:25 ET
966.17MMarket Cap-10192P/E (TTM)

EyePoint Pharmaceuticals Key Stats

EyePoint Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 7, 2024

Revenue(YoY)

14.03M

+33.18%
EPS(YoY)

-0.32

+72.41%

Strong Buy

Apr 30, 2024

EyePoint Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 9.017M--
--2024/Q1-- / 9.135M--
Mar 7, 20242023/Q414.028M / 8.703M--
Nov 1, 20232023/Q315.202M / 7.430M--
Aug 2, 20232023/Q29.105M / 42.126M--
May 3, 20232023/Q17.683M / 7.567M--
Mar 2, 20232022/Q410.533M / 10.403M--
Nov 2, 20222022/Q310.012M / 10.920M--
Aug 3, 20222022/Q211.565M / 10.864M--
May 4, 20222022/Q19.294M / 9.887M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 9.017M--
--2024/Q1-- / 9.135M--
Mar 7, 20242023/Q414.028M / 8.703M--
Nov 1, 20232023/Q315.202M / 7.430M--
Aug 2, 20232023/Q29.105M / 42.126M--
May 3, 20232023/Q17.683M / 7.567M--
Mar 2, 20232022/Q410.533M / 10.403M--
Nov 2, 20222022/Q310.012M / 10.920M--
Aug 3, 20222022/Q211.565M / 10.864M--
May 4, 20222022/Q19.294M / 9.887M--

Unlock Free Earnings Estimates

EyePoint Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg